These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24271521)

  • 21. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
    Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
    Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG; Bayon JE; González-Gallego J
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin.
    Natsuhori M; Witkamp RF; Van 't Klooster GA; Van Miert AS
    Xenobiotica; 1992 Nov; 22(11):1243-50. PubMed ID: 1492417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gonadal hormones on the plasma clearance and metabolite formation of antipyrine in the dwarf goat.
    Witkamp RF; Nijmeijer SM; Kolker HJ; Noordhoek J; van Miert AS
    J Vet Pharmacol Ther; 1993 Jun; 16(2):164-73. PubMed ID: 8345566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipyrine clearance and metabolite formation in primary biliary cirrhosis.
    Jorquera F; Almar M; Linares A; Olcóz JL; Rodrigo L; González-Gallego J
    Dig Dis Sci; 2001 Feb; 46(2):352-9. PubMed ID: 11281185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of sex and oral contraceptive steroids on antipyrine metabolite formation.
    Teunissen MW; Srivastava AK; Breimer DD
    Clin Pharmacol Ther; 1982 Aug; 32(2):240-6. PubMed ID: 7094512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
    Palette C; Cordonnier P; Naline E; Advenier C; Pays M
    J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
    van Bezooijen CF; van Oorschot RM
    J Pharmacol Exp Ther; 1989 Nov; 251(2):683-6. PubMed ID: 2810117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of liver damage on antipyrine metabolite formation in rats.
    Tanaka E; Etoh H; Ishikawa A; Nakano M; Misawa S
    Xenobiotica; 1991 May; 21(5):663-7. PubMed ID: 1949899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of cigarette smoke on antipyrine metabolite formation in rats.
    Nakagawa A; Chiba K; Ishizaki T; Nakamura K
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.
    Dahlqvist R; Bertilsson L; Birkett DJ; Eichelbaum M; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1984 Jun; 35(6):815-21. PubMed ID: 6734034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine.
    Brendel E; Meineke I; de Mey C
    J Pharm Biomed Anal; 1989; 7(12):1783-90. PubMed ID: 2490567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fluconazole on theophylline disposition in humans.
    Konishi H; Morita K; Yamaji A
    Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.
    Teunissen MW; Willemse PH; Sleijfer DT; Sluiter WJ; Breimer DD
    Cancer Chemother Pharmacol; 1984; 13(3):181-5. PubMed ID: 6207949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of enzyme induction on antipyrine metabolite formation.
    Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
    Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.